Nachrichten auf Deutsch aus internationalen Quellen.

World

DuPont SVP & general counsel Erik Hoover sells $633,896 in stock

Times News, Politik- und Marktübertrag (2026-11-09): DuPont de Nemours, Inc. (NYSE:DD - Get Free Report) SVP Erik Hoover sold 4,203 shares of DuPont de Nemours stock in a transaction that occurred on Monday,… Primärquelle: Original bei Investing.com UK All News (uk.investing.com).

· Investing.com UK All News

DuPont de Nemours, Inc. (NYSE:DD - Get Free Report) SVP Erik Hoover sold 4,203 shares of DuPont de Nemours stock in a transaction that occurred on Monday, November 9th. The shares were sold at an average price of $150.82, for a total transaction of $633,896.46. Following the completion of the transaction, the senior vice president owned 38,798 shares of the company's stock, valued at $5,851,514.36. This represents a 9.77% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

DuPont de Nemours Stock Performance

DD stock traded up $8.41 during midday trading on Monday, reaching $154.93. 1,101,344 shares of the company's stock traded hands, compared to its average volume of 1,350,165. The firm has a market capitalization of $20.53 billion, a PE ratio of 69.47, a price-to-earnings-growth ratio of 1.27 and a beta of 1.06. The company has a 50-day moving average price of $133.21 and a two-hundred day moving average price of $138.80. DuPont de Nemours, Inc. has a 52 week low of $111.15 and a 52 week high of $157.98. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.74 and a current ratio of 2.36.

DuPont de Nemours (NYSE:DD - Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The basic materials company reported $2.09 EPS for the quarter, topping analysts' consensus estimates of $1.87 by $0.22. The firm had revenue of $1.87 billion during the quarter, compared to analyst estimates of $1.84 billion. DuPont de Nemours had a return on equity of 6.85% and a net margin of 4.26%. The business's revenue for the quarter was up 4.1% on a year-over-year basis. During the same period last year, the company earned $1.09 earnings per share. As a group, equities analysts anticipate that DuPont de Nemours, Inc. will post 7.51 EPS for the current year.

DuPont de Nemours Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, November 30th will be issued a dividend of $0.60 per share. The ex-dividend date of this dividend is Monday, November 30th. This represents a $2.40 dividend on an annualized basis and a yield of 1.5%. DuPont de Nemours's dividend payout ratio is 107.62%.

Wall Street Analyst Weigh In

Several brokerages have commented on DD. JPMorgan Chase & Co. downgraded DuPont de Nemours from an "overweight" rating to a "neutral" rating and cut their target price for the stock from $172.00 to $145.00 in a research note on Friday, October 9th. Barclays upped their price target on DuPont de Nemours from $156.00 to $176.00 and gave the company an "overweight" rating in a research report on Wednesday, November 4th. Weiss Ratings reissued a "sell (d+)" rating on shares of DuPont de Nemours in a report on Friday, October 30th. The Goldman Sachs Group lowered their price target on shares of DuPont de Nemours from $159.00 to $153.00 and set a "neutral" rating on the stock in a report on Wednesday, September 30th. Finally, Zacks Research lowered shares of DuPont de Nemours from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 17th. Twelve research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $165.88.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Physician Wealth Advisors Inc. grew its position in DuPont de Nemours by 223.1% during the third quarter. Physician Wealth Advisors Inc. now owns 210 shares of the basic materials company's stock worth $27,000 after buying an additional 145 shares in the last quarter. Elevation Wealth Partners LLC raised its holdings in shares of DuPont de Nemours by 168.5% in the 2nd quarter. Elevation Wealth Partners LLC now owns 239 shares of the basic materials company's stock valued at $32,000 after acquiring an additional 150 shares in the last quarter. DHJJ Financial Advisors Ltd. raised its holdings in shares of DuPont de Nemours by 150.0% in the 3rd quarter. DHJJ Financial Advisors Ltd. now owns 250 shares of the basic materials company's stock valued at $32,000 after acquiring an additional 150 shares in the last quarter. Bangor Savings Bank purchased a new stake in shares of DuPont de Nemours in the 3rd quarter valued at about $36,000. Finally, Compass Wealth Management LLC bought a new stake in shares of DuPont de Nemours during the 3rd quarter valued at about $39,000. 73.96% of the stock is currently owned by hedge funds and other institutional investors.

DuPont de Nemours Company Profile

Get Free Report

DuPont de Nemours is a science and materials company that develops products for customers in markets including construction, healthcare, water treatment, transportation and worker safety. Its offerings include protective materials such as Kevlar, Nomex and Tyvek, as well as Corian surface materials and technologies used in water purification and separation.

The company traces its roots to 1802, when E. I. du Pont established a gunpowder mill in Delaware. Over time, DuPont expanded into a broad range of chemical and advanced-materials businesses.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Before you consider DuPont de Nemours, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DuPont de Nemours wasn't on the list.

While DuPont de Nemours currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Like this article? Share it with a colleague.